| Not Yet Recruiting | Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer NCT07302841 | Tianjin Medical University Cancer Institute and Hospital | Phase 4 |
| Enrolling By Invitation | Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastat NCT07386704 | Peking University First Hospital | Phase 2 |
| Active Not Recruiting | Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancr NCT07326150 | Zhejiang Cancer Hospital | — |
| Recruiting | Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System NCT06937996 | Englewood Hospital and Medical Center | — |
| Recruiting | Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer NCT07066995 | Essen Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic C NCT06916975 | Jin Xu | Phase 2 |
| Not Yet Recruiting | Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. NCT06888648 | Zhejiang University | Phase 1 / Phase 2 |
| Recruiting | Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. NCT06840067 | Gansu Wuwei Tumor Hospital | N/A |
| Not Yet Recruiting | Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography NCT06670547 | Germans Trias i Pujol Hospital | — |
| Recruiting | EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) NCT06375967 | Hospital Universitari de Bellvitge | N/A |
| Recruiting | Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer NCT06605430 | HealthPartners Institute | Phase 2 |
| Active Not Recruiting | Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer NCT07271823 | Zhejiang Cancer Hospital | — |
| Recruiting | A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer NCT06503497 | Zhejiang University | EARLY_Phase 1 |
| Recruiting | Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Can NCT06478459 | Zhejiang University | EARLY_Phase 1 |
| Not Yet Recruiting | Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer NCT06361030 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Not Yet Recruiting | Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer NCT06387368 | Xi'an Jiaotong University | Phase 4 |
| Recruiting | Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer NCT06160323 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT NCT05802485 | Institut Paoli-Calmettes | N/A |
| Unknown | Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System NCT05549414 | P-Cure | N/A |
| Recruiting | Pancreatic Cancer Detection Consortium NCT06388967 | City of Hope Medical Center | — |
| Active Not Recruiting | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) NCT05642962 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer NCT05424159 | Shanghai Proton and Heavy Ion Center | N/A |
| Unknown | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients NCT05047991 | CSPC Ouyi Pharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma NCT04986930 | Asan Medical Center | Phase 2 |
| Unknown | Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer NCT05262452 | Seoul National University Hospital | N/A |
| Withdrawn | PanDox: Targeted Doxorubicin in Pancreatic Tumours NCT04852367 | University of Oxford | Phase 1 |
| Unknown | RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer NCT04338763 | Rise Biopharmaceuticals, Inc. | Phase 1 |
| Unknown | Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients NCT05265663 | Amsterdam UMC, location VUmc | N/A |
| Completed | Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancrea NCT04156087 | Baki Topal | Phase 2 |
| Completed | INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampulla NCT04116073 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Active Not Recruiting | Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Sten NCT06453590 | Region Stockholm | N/A |
| Completed | Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Adv NCT03984214 | Arbeitsgemeinschaft medikamentoese Tumortherapie | Phase 3 |
| Recruiting | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Unknown | I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer NCT03964064 | Peking University Third Hospital | N/A |
| Completed | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy ( NCT03941093 | Kyntra Bio | Phase 3 |
| Completed | Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients T NCT03590275 | Azienda Ospedaliero, Universitaria Pisana | — |
| Unknown | Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer NCT03165591 | Immunitor LLC | Phase 1 / Phase 2 |
| Completed | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer NCT02128100 | University of Louisville | Phase 2 |
| Terminated | Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Canc NCT01887041 | Universitätsklinikum Hamburg-Eppendorf | Phase 4 |